Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$1.24M Buy
11,566
+630
+6% +$60.5K 0.56% 39
2020
Q3
$958K Buy
10,936
+812
+8% +$76.4K 0.51% 44
2020
Q2
$994K Buy
10,124
+748
+8% +$65.9K 0.62% 40
2020
Q1
$714K Sell
9,376
-464
-5% -$39.5K 0.54% 47
2019
Q4
$871K Buy
+9,840
New +$817K 0.47% 47

Other funds holding ABBV

Berry Group's ABBV Position: Q4 2020 in Review

Berry Group increased its AbbVie (ABBV) stake by 5.8% in Q4 2020, buying an estimated $60.5K and bringing the position to 11,566 shares worth $1.24M. The position accounts for 0.56% of the portfolio, ranked #39.

Berry Group first reported a position in ABBV in Q4 2019 and has held it in 5 quarters since. 2,597 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

  • Berry Group held 11,566 shares of AbbVie worth $1.24M as of Q4 2020.
  • Berry Group bought 630 AbbVie shares in Q4 2020, an estimated $60.5K.
  • AbbVie made up 0.56% of Berry Group's portfolio in Q4 2020, its #39 holding.
  • Berry Group first reported a position in AbbVie in Q4 2019 and has held it in 5 quarters since.
  • 2,597 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Berry Group's 13F filing for Q4 2020, filed 11 Feb 2021.